glp-1/glp-2 dual agonist The Emerging Role of GLP-1 and GIP Receptor Agonists in Glycemic Management and Cardiovascular Risk Reduction Engineering a potent and long-acting

Increasing evidence has demonstrated that GLP-1 analogues can cross the blood-brain barrier, protect dopaminergic neurons in the substantia nigra, and rescue motor activity and cognitive functions in PD animal models (5961)

For patients with severe obesity-related complications, providers may lean toward therapies with the strongest efficacy data currently available

This technology enables extended pharmacological activity through the site-specific conjugation of a cysteine-albuminconjugated Exendin-4 analog (CA-Exendin-4) to the Fc fragment of human immunoglobulin G subclass 4 (IgG4), linked via a flexible peptide spacer (Fig

Remember, the medication is not a substitute for a healthy diet it works best alongside good nutrition

To develop novel protease inhibitors with high activity and selectivity, grassypeptolide 59 was synthesized by Jason C

Gastrointestinal adverse events and weight reduction in people with type 2 diabetes treated with tirzepatide in the SURPASS clinical trials